Oral and upper respiratory tract pathogens

This target refers to the collective group of pathogenic microorganisms, including bacteria and fungi, that colonize the oral cavity and upper respiratory tract by adhering to mucosal surfaces and forming complex biofilm structures. These biofilms represent a significant therapeutic challenge as they provide a protective environment that shields pathogens from host immune responses and reduces the efficacy of conventional antibiotics. Key species involved in these processes include Streptococcus mutans, Porphyromonas gingivalis, and Streptococcus pneumoniae, which utilize specific ecological niches and biofilm interfaces to establish persistent infections. Therapeutic strategies targeting this interface often involve the use of probiotics for competitive exclusion, anti-adhesive molecules to prevent initial attachment, or agents that enzymatically degrade the biofilm matrix. Because this entry describes a broad ecological niche and a physical process involving multiple species rather than a single molecular entity like a protein or receptor, it is classified as an incorrect or non-canonical target for drug discovery purposes. Understanding the dynamics of these adhesion sites is critical for developing treatments for conditions ranging from dental caries to chronic sinusitis.

Other names

Oral biofilmUpper respiratory tract microbiotaEcological adhesion sitesBiofilm interfacesOral microflora

Competitive inhibition of ecological adhesion sites, disruption of the extracellular polymeric substance (EPS) matrix within biofilm interfaces, and direct antimicrobial activity via bacteriocins or oxidative stress.